Your browser doesn't support javascript.
loading
Compound heterozygous mutation of Rag1 leading to Omenn syndrome.
Matthews, Adam G W; Briggs, Christine E; Yamanaka, Keiichi; Small, Trudy N; Mooster, Jana L; Bonilla, Francisco A; Oettinger, Marjorie A; Butte, Manish J.
Afiliación
  • Matthews AG; Department of Molecular Biology, Massachusetts General Hospital and Department of Genetics, Harvard Medical School, Boston, MA 02114, United States of America; Department of Biological Sciences, Wellesley College, 106 Central St., Wellesley, MA, 02481, United States of America.
  • Briggs CE; Molecular Genetics Core Facility, Children's Hospital Boston, Boston, MA 02115, United States of America.
  • Yamanaka K; Department of Dermatology, Mie University, Graduate School of Medicine, Mie 514-8507, Japan.
  • Small TN; Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, United States of America.
  • Mooster JL; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Boston Children's Hospital, Boston, MA 02115, United States of America.
  • Bonilla FA; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Boston Children's Hospital, Boston, MA 02115, United States of America.
  • Oettinger MA; Department of Molecular Biology, Massachusetts General Hospital and Department of Genetics, Harvard Medical School, Boston, MA 02114, United States of America.
  • Butte MJ; Department of Pediatrics, Division of Immunology, Allergy, and Rheumatology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, United States of America.
PLoS One ; 10(4): e0121489, 2015.
Article en En | MEDLINE | ID: mdl-25849362
ABSTRACT
Omenn syndrome is a primary immunodeficiency disorder, featuring susceptibility to infections and autoreactive T cells and resulting from defective genomic rearrangement of genes for the T cell and B cell receptors. The most frequent etiologies are hypomorphic mutations in "non-core" regions of the Rag1 or Rag2 genes, the protein products of which are critical members of the cellular apparatus for V(D)J recombination. In this report, we describe an infant with Omenn syndrome with a previously unreported termination mutation (p.R142*) in Rag1 on one allele and a partially characterized substitution mutation (p.V779M) in a "core" region of the other Rag1 allele. Using a cellular recombination assay, we found that while the p.R142* mutation completely abolished V(D)J recombination activity, the p.V779M mutation conferred a severe, but not total, loss of V(D)J recombination activity. The recombination defect of the V779 mutant was not due to overall misfolding of Rag1, however, as this mutant supported wild-type levels of V(D)J cleavage. These findings provide insight into the role of this poorly understood region of Rag1 and support the role of Rag1 in a post-cleavage stage of recombination.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Proteínas de Homeodominio / Mutación Missense / Alelos / Heterocigoto Límite: Child / Child, preschool / Humans / Infant / Male / Newborn Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunodeficiencia Combinada Grave / Proteínas de Homeodominio / Mutación Missense / Alelos / Heterocigoto Límite: Child / Child, preschool / Humans / Infant / Male / Newborn Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos